Implicaciones Económicas de una Vacuna Diferencial para la Fiebre Aftosa
##plugins.themes.bootstrap3.article.sidebar##
Publicado
jun 5, 2015
##plugins.themes.bootstrap3.article.main##
Resumen
La fiebre aftosa es una de las enfermedades zoonóticas con los impactos económicos más altos y las tasas de contagio más rápidas. Existen diferentes estrategias para controlar los brotes de fiebre aftosa, por ejemplo el sacrificio de los animales infectados y la vacunación. Sin embargo, las diferencias económicas y sociales del uso de estas estrategias son enormes. El desarrollo e introducción de las vacunas diferenciales entre animales infectados y vacunados (DIVA por sus siglas en inglés) y sus pruebas de diagnóstico, representarían un avance científico que cambiaría la forma de las campañas de erradicación así como el comportamiento de los mercados de productos cárnicos. Las vacunas DIVA hacen posible la vacunación masiva de la población animal susceptible, sin comprometer la identificación serológica de los animales convalecientes. El objetivo de este artículo es presentar una descripción de las implicaciones económicas de la introducción de una vacuna DIVA tanto para los países actualmente libres de fiebre aftosa como los países donde la fiebre aftosa endémica. Para el Ecuador, dada la importante inversión en los últimos años para declarar al país libre de aftosa, las vacunas DIVA abren la posibilidad de controlar brotes que eviten el cierre de mercados internacionales.
Palabras clave
Análisis costo beneficio, enfermedades zoonóticas, bioseguridad, medidas de respuesta
##plugins.themes.bootstrap3.article.details##
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
Este obra está bajo una licencia de Creative Commons Reconocimiento 4.0 Internacional
Citas
Abdalla, A., Beare, S., Cao, L., Garner, G., & Heaney, A. (2005). Foot and Mouth Disease: Evaluating Alternatives for Controlling a Possible Outbreak. Canberra: ABARE.
APHIS Veterinary Services. (2007, March). Foot-and-Mouth Disease VAccine. Factsheet .
Blackman, A. (1999). The Economics of Technology Diffusion: Implications for Climate Policy in Developing Countries. Discussion Paper 99 - 42 .
Conway, G., & Jeff, W. (2010). Science and Innovation for Development. UK Collaborative on Development Sciences.
DEFRA. (2010). Vaccination as a Control Tool for Exotic Animal Disease - Key Considerations.
Douthwait, B., Keatinge, J., & Park, J. (2002). Learning selection: an evolutionary model for undeerstandig, implementing and evaluating participatory technology developmgen. Agricultural Systems , 72, 109-131.
Elbakidze, L., & McCarl, B. A. (2006). Animal Disease Pre Event Preparedness versus Post Event Response: When is it Economic to Protect? Journal of Agricultural and Applied Economics , 38 (2), 327-336.
Finkelstein, A. (2004). Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry. The Quarterly Journal of Economics , 119 (2), 527-564.
Foord, A. J., Muller, J. D., Meng, Y., Lin-Fa, W., & Hans, G. H. (2007). Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC. Journal of Inmunological Methods , 321, 142-151.
Foord, A. J., Muller, J. D., Yu, M., Wang, L.-F., & Heine, H. G. (2007). Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural proteing 3ABC. Journal of Immunological Methods , 321, 142-151.
Guidelines. (2007, April). North American Foot and Mouth Disease Vaccine Bank .
Hagel, J., & Brown, J. (2005). From push to pull -emerging models for mobilizing resources. Working Paper, October, 2005.
Hennessy, D. A. (2007). Behavioral incentives, equilibrium endemic disease, and health managemente policy for farmed animals. American Journal of Agricultural Economics , 89 (3), 698-711.
Hsu, J. C., & Schwartz, E. S. (2008). A model of R&D valuation and the design of research incentives. Insurance: Mathematics and Economics , 43, 350-367.
Hunter, P. (1998). Vaccination as a means of control of foot-and-mouth disease in sub-saharan Africa . Vaccine , 16 (2-3), 261-264.
Jorgenson, D. W., & Griliches, Z. (1967). The Explanation of Productivity Change. The Review of Economic Studies , 34 (3), 249-283.
Junker, F., Komorowska, J., & van Tongeren, F. (2008). Impact of Animal disease Outbreaks and Alternative Control Practices on Agricultural Markets and Trade: The case of FMD. OECD publishing.
Just, R. E., Hueth, D. L., & Schmitz, A. (2004). The Welfare Economics of Public Policy: A Practical Approach to Project and Policy Evaluation. Edward Elgar Publishing Co.
Mansfield, E. (1961). Technical Change and the Rate of Imitation. Econometrica , 29, 741-765.
Mason, P. W., & Grubman, M. J. (2009). Foot-and-Mouth Disease. In A. D. Barrett, & L. R. Stanberry (Eds.), Vaccines for Biodefense and Emerging and Neglected Diseases (pp. 361-377). Elservier Ltd.
McLeod, A., & Leslie, J. (2001). Socio-economic impacts of freedom from livestock disease and export promotion in developing countries. Livestock Policy Discussion Paper No. 1. Rome: Food and Agriculture Organization.
McLeod, A., & Rushton, J. (2007). Economics of Animal Vaccination. Revue Scientifique et Technique , 26 (2), 313-326.
Meuwissen, M., Horst, S., Huirne, R., & Dijkhuizen, A. (1999). A model to estimate the finanacialconsequences of classical swine fever outbreaks: principles and outcomes. Preventive Veterinary Medicine , 42 (3-4), 249-270.
Muller, J. D., Wilkins, M., Foord, A. J., Dolezal, O., Yu, M., Heine, H. G., et al. (2010). Improvement of a recombinant antibody-based serikigucak assat for foot-and-mouth disease virus. Journal of Immunological Methods , 352, 81-88.
Nature Biotechnology. (2007). Stop the cull. Editorial.
OIE. (2006). Retrieved September 26, 2010, from http://www.oie.int/eng/info/en_fmd.htm
Olmstead, A. L. (2009). The First Line of Defense: Inventing the Infrastructure to Combat Animal Diseases. The Journal of Economic History , 69 (2), 327-357.
Pasick, J. (2004). Application of DIVA vaccines and their companion diagnostic tests to foreign animal disease eradication. Animal Health Research Reviews , 5 (2), 257 - 262.
Petroski, H. (1994). The Evolution of Useful Things. New York: Vintage Books USA.
Rich, K. M., & Winter-Nelson, A. (2007). An integrated epidemiological-economic analysis of foot and mouth disease: applications to the southern cone of South America. American Journal of Agricultural Economics , 89 (3), 682-697.
Risk Solutions. (2005). Cost Benefit Analysis of Foot-and-Mouth Disease Controls. A Report for the Department of Food and Rural Affairs. Retrieved October 9, 2010, from http://www.defra.gov.uk/foodfarm/farmanimal/diseases/atoz/fmd/control/policy.htm
Sassenrath, G., Heilman, P., Luschei, E., Bennett, G., Fitzgerald, G., Klesius, P., et al. (2008). Technology, complexity and change in agricultural production systems. Renewable Agriculture and Food Systems , 23 (4), 285-295.
Van Oirschot, J. (1999). Diva vaccines that reduce virus transmission. Journal of Biotechnology , 73, 195-205.
Whiting, T. (2006). Welfare Slaughter of Livestock in Emergency Situations. The Canadian Veterinary Journal , 47 (8), 737.
Código Sanitario para los animales terrestres 2014. Organización Mundial de Sanidad Animal.
Berentsen. P.B.M., Dijkhuizen, AA., Oskam., A.J. (1992). A dynamic model for cost-benefit analysis of foot-and-mouth disease control strategies. Preventive Veterinary Medicine, 12 (1992), 229-243.
http://www.animalhealthaustralia.com.au/programs/emergency-animal-disease-preparedness/ausvetplan/fmd-response-policy-review/vaccination-faqs/
APHIS Veterinary Services. (2007, March). Foot-and-Mouth Disease VAccine. Factsheet .
Blackman, A. (1999). The Economics of Technology Diffusion: Implications for Climate Policy in Developing Countries. Discussion Paper 99 - 42 .
Conway, G., & Jeff, W. (2010). Science and Innovation for Development. UK Collaborative on Development Sciences.
DEFRA. (2010). Vaccination as a Control Tool for Exotic Animal Disease - Key Considerations.
Douthwait, B., Keatinge, J., & Park, J. (2002). Learning selection: an evolutionary model for undeerstandig, implementing and evaluating participatory technology developmgen. Agricultural Systems , 72, 109-131.
Elbakidze, L., & McCarl, B. A. (2006). Animal Disease Pre Event Preparedness versus Post Event Response: When is it Economic to Protect? Journal of Agricultural and Applied Economics , 38 (2), 327-336.
Finkelstein, A. (2004). Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry. The Quarterly Journal of Economics , 119 (2), 527-564.
Foord, A. J., Muller, J. D., Meng, Y., Lin-Fa, W., & Hans, G. H. (2007). Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC. Journal of Inmunological Methods , 321, 142-151.
Foord, A. J., Muller, J. D., Yu, M., Wang, L.-F., & Heine, H. G. (2007). Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural proteing 3ABC. Journal of Immunological Methods , 321, 142-151.
Guidelines. (2007, April). North American Foot and Mouth Disease Vaccine Bank .
Hagel, J., & Brown, J. (2005). From push to pull -emerging models for mobilizing resources. Working Paper, October, 2005.
Hennessy, D. A. (2007). Behavioral incentives, equilibrium endemic disease, and health managemente policy for farmed animals. American Journal of Agricultural Economics , 89 (3), 698-711.
Hsu, J. C., & Schwartz, E. S. (2008). A model of R&D valuation and the design of research incentives. Insurance: Mathematics and Economics , 43, 350-367.
Hunter, P. (1998). Vaccination as a means of control of foot-and-mouth disease in sub-saharan Africa . Vaccine , 16 (2-3), 261-264.
Jorgenson, D. W., & Griliches, Z. (1967). The Explanation of Productivity Change. The Review of Economic Studies , 34 (3), 249-283.
Junker, F., Komorowska, J., & van Tongeren, F. (2008). Impact of Animal disease Outbreaks and Alternative Control Practices on Agricultural Markets and Trade: The case of FMD. OECD publishing.
Just, R. E., Hueth, D. L., & Schmitz, A. (2004). The Welfare Economics of Public Policy: A Practical Approach to Project and Policy Evaluation. Edward Elgar Publishing Co.
Mansfield, E. (1961). Technical Change and the Rate of Imitation. Econometrica , 29, 741-765.
Mason, P. W., & Grubman, M. J. (2009). Foot-and-Mouth Disease. In A. D. Barrett, & L. R. Stanberry (Eds.), Vaccines for Biodefense and Emerging and Neglected Diseases (pp. 361-377). Elservier Ltd.
McLeod, A., & Leslie, J. (2001). Socio-economic impacts of freedom from livestock disease and export promotion in developing countries. Livestock Policy Discussion Paper No. 1. Rome: Food and Agriculture Organization.
McLeod, A., & Rushton, J. (2007). Economics of Animal Vaccination. Revue Scientifique et Technique , 26 (2), 313-326.
Meuwissen, M., Horst, S., Huirne, R., & Dijkhuizen, A. (1999). A model to estimate the finanacialconsequences of classical swine fever outbreaks: principles and outcomes. Preventive Veterinary Medicine , 42 (3-4), 249-270.
Muller, J. D., Wilkins, M., Foord, A. J., Dolezal, O., Yu, M., Heine, H. G., et al. (2010). Improvement of a recombinant antibody-based serikigucak assat for foot-and-mouth disease virus. Journal of Immunological Methods , 352, 81-88.
Nature Biotechnology. (2007). Stop the cull. Editorial.
OIE. (2006). Retrieved September 26, 2010, from http://www.oie.int/eng/info/en_fmd.htm
Olmstead, A. L. (2009). The First Line of Defense: Inventing the Infrastructure to Combat Animal Diseases. The Journal of Economic History , 69 (2), 327-357.
Pasick, J. (2004). Application of DIVA vaccines and their companion diagnostic tests to foreign animal disease eradication. Animal Health Research Reviews , 5 (2), 257 - 262.
Petroski, H. (1994). The Evolution of Useful Things. New York: Vintage Books USA.
Rich, K. M., & Winter-Nelson, A. (2007). An integrated epidemiological-economic analysis of foot and mouth disease: applications to the southern cone of South America. American Journal of Agricultural Economics , 89 (3), 682-697.
Risk Solutions. (2005). Cost Benefit Analysis of Foot-and-Mouth Disease Controls. A Report for the Department of Food and Rural Affairs. Retrieved October 9, 2010, from http://www.defra.gov.uk/foodfarm/farmanimal/diseases/atoz/fmd/control/policy.htm
Sassenrath, G., Heilman, P., Luschei, E., Bennett, G., Fitzgerald, G., Klesius, P., et al. (2008). Technology, complexity and change in agricultural production systems. Renewable Agriculture and Food Systems , 23 (4), 285-295.
Van Oirschot, J. (1999). Diva vaccines that reduce virus transmission. Journal of Biotechnology , 73, 195-205.
Whiting, T. (2006). Welfare Slaughter of Livestock in Emergency Situations. The Canadian Veterinary Journal , 47 (8), 737.
Código Sanitario para los animales terrestres 2014. Organización Mundial de Sanidad Animal.
Berentsen. P.B.M., Dijkhuizen, AA., Oskam., A.J. (1992). A dynamic model for cost-benefit analysis of foot-and-mouth disease control strategies. Preventive Veterinary Medicine, 12 (1992), 229-243.
http://www.animalhealthaustralia.com.au/programs/emergency-animal-disease-preparedness/ausvetplan/fmd-response-policy-review/vaccination-faqs/